Top analysts on stock perps · Analyst
Terence Flynn (Morgan Stanley): analyst track record on stock perps
Terence Flynn of Morgan Stanley on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.7★
Success59%
Excess return+9.8%
rank#733
Ratings409
ratings on stock perps608
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 296 | 799 |
| Stock | 47 | 49 |
| Buy / hold / sell | 152 / 123 / 21 | 377 / 372 / 50 |
| Upgrades / downgrades / initiations | 4 / 2 / 1 | 8 / 5 / 5 |
| Price targets hit / missed | 146 / 146 (50%) | 456 / 333 (58%) |
| Avg. return after a rating (TipRanks) | +24.0% | +22.9% |
| Best / worst call | +626.3% / -82.7% | +626.3% / -86.6% |
After buy calls: median 21-day move +0.5% · vs S&P 500 -1.7% (n = 255) · targets hit within a year 44% (n = 171)
After sell calls: median 21-day move +0.1% · vs S&P 500 -0.6% (n = 33)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $BNTX BioNTech SE | Buy · Reiterated | $114 | +29.4% | Oct 26, 2026 |
| $ABBV AbbVie Inc. | Buy · Maintained | $310 | +8.5% | Oct 22, 2026 |
| $GILD Gilead Sciences, Inc. | Buy · Maintained | $163 | +4.5% | Oct 22, 2026 |
| $JNJ Johnson & Johnson | Buy · Reiterated | $292 | +10.7% | Oct 15, 2026 |
| $BMY Bristol Myers Squibb | Sell · Maintained | $41.00 | -33.3% | Oct 12, 2026 |
| $LLY Eli Lilly and Company | Buy · Maintained | $1,430 | +12.3% | Oct 9, 2026 |
| $AMGN Amgen Inc. | Hold · Maintained | $359 | -18.3% | Oct 7, 2026 |
| $MRK Merck & Co., Inc. | Buy · Maintained | $177 | +21.8% | Oct 7, 2026 |
| $MRNA Moderna, Inc. | Hold · Reiterated | $95.00 | -52.5% | Oct 7, 2026 |
| $PFE Pfizer Inc. | Hold · Reiterated | $28.00 | -6.8% | Oct 7, 2026 |
| $REGN Regeneron Pharmaceuticals, Inc. | Hold · Maintained | $779 | -3.2% | Oct 7, 2026 |
| $VRTX Vertex Pharmaceuticals | Buy · Reiterated | $665 | +26.9% | Oct 7, 2026 |
| $BIIB Biogen Inc. | Hold · Maintained | $231 | -7.9% | Jul 30, 2026 |
Recent ratings
- Oct 26, 2026 $BNTX: Reiterated · Buy · $114 · article
- Oct 22, 2026 $ABBV: Maintained · Buy · $310 · article
- Oct 22, 2026 $GILD: Maintained · Buy · $163 · article
- Oct 22, 2026 $ABBV: Maintained · Buy · $310
- Oct 19, 2026 $BNTX: Reiterated · Buy · $114 · article
- Oct 15, 2026 $JNJ: Reiterated · Buy · $292 · article
- Oct 13, 2026 $JNJ: Maintained · Buy · $294 · article
- Oct 12, 2026 $BMY: Maintained · Sell · $41.00 · article
- Oct 12, 2026 $BNTX: Reiterated · Buy · $114 · article
- Oct 12, 2026 $BMY: Maintained · Sell · $41.00
- Oct 7, 2026 $JNJ: Reiterated · Buy · $294 · article
- Oct 7, 2026 $VRTX: Reiterated · Buy · $665 · article
- Oct 7, 2026 $PFE: Reiterated · Hold · $28.00 · article
- Oct 9, 2026 $LLY: Maintained · Buy · $1,430 · article
- Oct 7, 2026 $LLY: Maintained · Buy · $1,430 · article
- Oct 7, 2026 $GILD: Maintained · Buy · $163 · article
- Oct 7, 2026 $BMY: Maintained · Sell · $41.00 · article
- Oct 7, 2026 $ABBV: Reiterated · Buy · $310 · article
- Oct 7, 2026 $REGN: Maintained · Hold · $779 · article
- Oct 7, 2026 $MRNA: Reiterated · Hold · $95.00 · article
Terence Flynn4.7★ · 59% success · +9.8% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.